These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 16391181
1. Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy. Van Den Bossche B, Van Belle S, De Winter F, Signore A, Van de Wiele C. J Nucl Med; 2006 Jan; 47(1):6-13. PubMed ID: 16391181 [Abstract] [Full Text] [Related]
2. 99mTc depreotide scan compared with 99mTc-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer. Van Den Bossche B, D'haeninck E, De Winter F, Van Belle S, Dierckx RA, Van De Wiele C. Nucl Med Commun; 2004 Aug; 25(8):787-92. PubMed ID: 15266172 [Abstract] [Full Text] [Related]
3. Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with 99mTc-depreotide. Van Den Bossche B, D'haeninck E, De Vos F, Dierckx RA, Van Belle S, Bracke M, Van de Wiele C. Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):1022-30. PubMed ID: 15029461 [Abstract] [Full Text] [Related]
6. Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer. Axelsson R, Herlin G, Bååth M, Aspelin P, Kölbeck KG. Acta Radiol; 2008 Apr; 49(3):295-302. PubMed ID: 18365818 [Abstract] [Full Text] [Related]
7. 99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer. Rodrigues M, Li S, Gabriel M, Heute D, Greifeneder M, Virgolini I. J Clin Endocrinol Metab; 2006 Oct; 91(10):3997-4000. PubMed ID: 16895961 [Abstract] [Full Text] [Related]
9. Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules. Grewal RK, Dadparvar S, Yu JQ, Babaria CJ, Cavanaugh T, Sherman M, Jacobstein J. Cancer J; 2002 Oct; 8(5):400-4. PubMed ID: 12416898 [Abstract] [Full Text] [Related]
10. The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR. Wang F, Wang Z, Wu J, Qu W, Yao W, Zhao J, Liu Z. Nucl Med Biol; 2008 Aug; 35(6):665-71. PubMed ID: 18678351 [Abstract] [Full Text] [Related]
16. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors. Gabriel M, Decristoforo C, Donnemiller E, Ulmer H, Watfah Rychlinski C, Mather SJ, Moncayo R. J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671 [Abstract] [Full Text] [Related]
17. Accumulation of Tc-99m depreotide (NeoSpect) in axillary sweat glands. Danielsson R, Bååth M, Kölbeck KG, Klominek J, Svensson L. Clin Nucl Med; 2003 Sep; 28(9):789-90. PubMed ID: 12973013 [Abstract] [Full Text] [Related]
18. Limited value of ⁹⁹mTc depreotide single photon emission CT compared with CT for the evaluation of pulmonary lesions. Harders SW, Madsen HH, Hjorthaug K, Rehling M, Rasmussen TR, Pedersen U, Pilegaard HK, Meldgaard P, Baandrup UT, Rasmussen F. Br J Radiol; 2012 Jul; 85(1015):e307-13. PubMed ID: 22745210 [Abstract] [Full Text] [Related]
19. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT. Naalsund A, Maublant J. Respiration; 2006 Jul; 73(5):634-41. PubMed ID: 16679755 [Abstract] [Full Text] [Related]